Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 111

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata

Raja, Alsaba F, Ali, Furqan, Khan, Inshad A, Shawl, Abdul S, Arora, Daljit S, Shah, Bhahwal A, Taneja, Subhash C·2011·BMC Microbiology
DOI 10.1186/1471-2180-11-54
Open this paper in CoChat — free account

Abstract

Background: Boswellic acids are pentacyclic triterpenes, which are produced in plants belonging to the genus Boswellia. Boswellic acids appear in the resin exudates of the plant and it makes up 25-35% of the resin. β-boswellic acid, 11-keto-β-boswellic acid and acetyl-11-keto-β-boswellic acid have been implicated in apoptosis of cancer cells, particularly that of brain tumors and cells affected by leukemia or colon cancer. These molecules are also associated with potent antimicrobial activities. The present study describes the antimicrobial activities of boswellic acid molecules against 112 pathogenic bacterial isolates including ATCC strains. Acetyl-11-keto-β-boswellic acid (AKBA), which exhibited the most potent antibacterial activity, was further evaluated in time kill studies, postantibiotic effect (PAE) and biofilm susceptibility assay. The mechanism of action of AKBA was investigated by propidium iodide uptake, leakage of 260 and 280 nm absorbing material assays. Results: AKBA was found to be the most active compound showing an MIC range of 2-8 μg/ml against the entire gram positive bacterial pathogens tested. It exhibited concentration dependent killing of Staphylococcus aureus ATCC 29213 up to 8 × MIC and also demonstrated postantibiotic effect (PAE) of 4.8 h at 2 × MIC. Furthermore, AKBA inhibited the formation of biofilms generated by S. aureus and Staphylococcus epidermidis and also reduced the preformed biofilms by these bacteria. Increased uptake of propidium iodide and leakage of 260 and 280 nm absorbing material by AKBA treated cells of S aureus indicating that the antibacterial mode of action of AKBA probably occurred via disruption of microbial membrane structure. Conclusions: This study supported the potential use of AKBA in treating S. aureus infections. AKBA can be further exploited to evolve potential lead compounds in the discovery of new anti-Gram-positive and anti-biofilm agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2180-11-54

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 52

  1. Tacconelli E, Angelis GD, Cataldo AM, Pozzi E, Cauda R: Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008, 61: 26-38. 10.1093/jac/dkm416. · DOI · Paper page
  2. Millar BC, Prendergast BD, Moore JE: Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother. 2008, 61: 1-7. 10.1093/jac/dkm410. · DOI
  3. Hiramatsu K: Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001, 1: 1470-55. 10.1016/S1473-3099(01)00091-3. · DOI · Paper page
  4. Dancer SJ: The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2008, 61: 246-253. 10.1093/jac/dkm465. · DOI
  5. Brown MR, Allison DG, Gilbert P: Resistance of bacterial biofilms to antibiotics: a growth-rate related effect?. J Antimicrob Chemother. 1998, 22: 777-780. 10.1093/jac/22.6.777. · DOI
  6. Chambers HF: The changing epidemiology of Staphylococcus aureus. Emerg. Infect Dis. 2001, 17: 178-182. · DOI · Paper page
  7. Stewart PS: Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbio. 2002, 292: 107-113. 10.1078/1438-4221-00196. · DOI
  8. Shirtliff ME, Mader JT, Camper AK: Molecular interactions in biofilms. Chem Biol. 2002, 9: 859-865. 10.1016/S1074-5521(02)00198-9. · DOI
  9. Adam B, Baillie GS, Douglas LJ: Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol. 2002, 51: 344-349. · DOI · Paper page
  10. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF: Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces. Antimicrob Agents Chemother. 2003, 47: 3407-3414. 10.1128/AAC.47.11.3407-3414.2003. · DOI · Paper page
  11. Costerton J: Introduction to biofilm. Inter J Antimicro Agents. 1999, 11: 217-221. 10.1016/S0924-8579(99)00018-7. · DOI · Paper page
  12. Yuan G, He G, Yang ML: Natural products and anti-inflammatory activity. Asia Pacific J Clin Nutrition. 2006, 15: 143-152.
  13. Kirtikar KR, Basu BD: In Indian Medicinal Plants. 1935, M/s Periodical Experts. Delhi, India, I: 521-2
  14. Chatterjee GK, Pal SD: Anti-inflammatory agents from Indian medicinial Plants. Indian Drugs. 1984, 21: 431-
  15. Moore PD: Conservation biology: Unkind cuts for incense. Nature. 2006, 444: 829-10.1038/444829a. · DOI
  16. Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN: Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg Med Chem Lett. 2007, 17: 3706-3711. 10.1016/j.bmcl.2007.04.034. · DOI
  17. Safayhi H, Sailer ER, Ammon HP: Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol. 1995, 47: 1212-1216. · DOI
  18. Safayhi H, Rall B, Sailer ER, Ammon HP: Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther. 1997, 281: 460-463. · DOI
  19. Krieglstein CF, Anthoni C, Rijcken EJ, Laukotter M, Spiegel HU, Boden SE, Schweizer S, Safayhi H, Senninger N, Schurmann G: Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int J Colorectal Dis. 2001, 16: 88-95. 10.1007/s003840100292. · DOI
  20. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R: Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol. 2001, 39: 11-17. 10.1055/s-2001-10708. · DOI
  21. Kimmatkar N, Thawani V, Hingorani L, Khiyani R: Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial. Phytomed. 2003, 10: 3-7. 10.1078/094471103321648593. · DOI
  22. Pardhy RS, Bhattacharya SC: Boswellic acid, acetyl- b-boswellic, acid-11- keto-b-boswellic acid and 11-keto-β-boswellic acids from the resin of Boswellia serrata Roxb. Ind J Chem. 1978, 16B: 176-178.
  23. Costerton J, Stewart P, Greenberg E: Bacterial biofilms: a common cause of persistent infections. Science. 1999, 284: 1318-1322. 10.1126/science.284.5418.1318. · DOI · Paper page
  24. Dunne WM: Bacterial adhesion: seen any good biofilms lately?. Clin Microbiol Rev. 2002, 15: 155-166. 10.1128/CMR.15.2.155-166.2002. · DOI · Paper page
  25. Gupta I, Parihar A, Singh GB, Ludtke R, Safayhi H, Ammon HP: Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997, 2: 37-43.
  26. Reddy GK, Dhar SC: Effect of a new non-steroidal anti-inflammatory agent on lysosomal stability in adjuvant induced arthritis. Ital J Biochem. 1987, 36: 205-217.
  27. Sharma ML, Bani S, Singh GB: Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharma. 1989, 11: 647-652. 10.1016/0192-0561(89)90150-1. · DOI
  28. Anderson KM, Seed T, Plate JM, Jajeh A, Meng J, Harris JE: Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis. Leukotr Res. 1993, 19: 789-801. 10.1016/0145-2126(95)00043-7. · DOI
  29. Abdallah EM, Khalid AS, Ibrahim N: Antibacterial activity of oleo-gum resins of Commiphora molmol and Boswellia papyrifera against methicillin resistant Staphylococcus aureus (MRSA). Sci Res Essay. 2009, 4: 351-356.
  30. Camarda L, Dayton T, Di Stefano V, Pitonzo R, Schillaci D: Chemical composition and antimicrobial activity of some oleo gum resin essential oils from Boswellia spp. (Burseraceae). Ann Chim. 2007, 97 (9): 837-44. 10.1002/adic.200790068. · DOI
  31. Kasali AA, Adio AM, Kundaya OE, Oyedeji AO, Eshilokun AO, Adefenwa M: Antimicrobial activity of the essential oil of Boswellia serrata Roxb. J Essent Oil Bearing Plants. 2002, 5 (3): 173-175.
  32. Weckessera S, Engela K, Simon-Haarhausa B, Wittmerb A, Pelzb K, Schemppa CM: Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine. 2007, 14: 508-516. 10.1016/j.phymed.2006.12.013. · DOI
  33. Hancock RE: The bacterial outer membrane as a drug barrier. Trends Microbiol. 1997, 5: 37-42. 10.1016/S0966-842X(97)81773-8. · DOI · Paper page
  34. Gallucci MN, Oliva M, Casero C, Dambolena J, Luna A, Zygadlob J, Demo M: Antimicrobial combined action of terpenes against the food-borne microorganisms Escherichia coli, Staphylococcus aureus and Bacillus cereus. Flavour Fragr J. 2009, 24: 348-354. 10.1002/ffj.1948. · DOI
  35. Reddy MV, Thota N, Sangwan PL, Malhotra P, Ali F, Khan IA, Chimni SS, Koul S: Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens. Eur J Med Chem. 2010, 45: 3125-3134. 10.1016/j.ejmech.2010.03.049. · DOI
  36. Burlando B, Parodi A, Volante A, Bassi AM: Comparison of the irritation potentials of Boswellia serrata gum resin and of acetyl-11-keto-boswellic acid by in vitro cytotoxicity tests on human skin-derived cell lines. Toxicol Lett. 1993, 177: 144-149. 10.1016/j.toxlet.2008.01.008. · DOI
  37. Magesh V, Raman D, Pudupalayam KT: Genotoxicity studies of dry extract of Boswellia serrata. Tropical J Pharmaceutical Research. 2008, 7 (4): 1129-1135. · DOI
  38. Shah BA, Kumar A, Gupta P, Sharma M, Sethi VK, Saxena AK, Singh J, Qazi GN, Taneja SC: Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids. Bioorg Med Chem Lett. 2007, 17: 6411-6416. 10.1016/j.bmcl.2007.10.011. · DOI
  39. Ammon HP, Safayhi H, Mack T, Sabieraj J: Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. 1993, 38: 113-119. 10.1016/0378-8741(93)90005-P. · DOI
  40. Abdel TM, Kaunzinger A, Bahr U, Karas M, Wurglics M, SchubertZsilavecz M: Development of a high performance liquid chromatographic method for the determination of 11 keto beta boswellic acid in human plasma. J Chromatogr Biomed Appl. 2001, 761: 221-227. 10.1016/S0378-4347(01)00335-8. · DOI
  41. Buechele B, Simmet T: Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high performance liquid chromatography and photodiode array detection. J Chromatogr. 2003, 795: 355-362. 10.1016/S1570-0232(03)00555-5. · DOI
  42. Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R: Pharmacokinetic study of 11 keto beta boswellic acid. Phytomedicine. 2004, 11: 1255-1260. 10.1078/0944-7113-00290. · DOI
  43. Reising K, Meins J, Bastian B, Eckert G, Mueller WE, Schubert-Zsilavecz M, Abdel Tawab M: Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem. 2005, 77: 6640-6645. 10.1021/ac0506478. · DOI
  44. Sterk V, Buchele B, Simmet T: Effect of food intake on the bioavaliability of boswellic acids from an herbal preparation in healthy volunteers. Planta Med. 2004, 70: 1155-1160. 10.1055/s-2004-835844. · DOI
  45. Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A7. 2006, Wayne, PA: CLSI, 7
  46. Eliopoulus GM, Moellering RCJ: Antimicrobial combinations. Antibiotics in Laboratory Medicine. Edited by: Lorian V. 1996, Baltimore, MD: The Williams & Wilkins Co, 330-396. 4
  47. Craig WA, Gudmundsson S: Postantibiotic effect. Antibiotics in laboratory medicine. Edited by: Lorian V. 1996, Williams and Wilkins Co., Baltimore, MD, 296-329. 4
  48. Wei GX, Campagna AN, Bokek LA: Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Agents. 2006, 57: 1100-1109. 10.1093/jac/dkl120. · DOI
  49. Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG: The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tree oil). J App Microbio. 2000, 88: 170-175. 10.1046/j.1365-2672.2000.00943.x. · DOI · Paper page
  50. Lo'pez-Amoro's R, Comas J, Vives-Rego J: Flow cytometric assessment of Escherichia coli and Salmonella typhimurium starvation-survival in seawater using rhodamine 123, propidium iodide, and oxonol. Appl Environ Microbiol. 1995, 61: 2521-2526. · DOI
  51. Hilliard JJ, Goldschmidt RM, Licata L, Baum EZ, Bush K: Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother. 1999, 43: 1693-1699. · DOI
  52. Cox SD, Mann CM, Markham JL, Gustafson JE, Warmington JR, Wyllie SG: Determining the Antimicrobial Actions of Tea Tree Oil. Molecules. 2001, 6: 87-91. 10.3390/60100087. · DOI · Paper page

Cited by

Metadata

Authors
Raja, A. F., Ali, F., Khan, I. A., Shawl, A. S., Arora, D. S., Shah, B. A., & Taneja, S. C.
Venue
BMC Microbiology
Publisher
Springer Science and Business Media LLC
Published
2011-03-16
Volume
11
Issue
1
ISSN
1471-2180
DOI
10.1186/1471-2180-11-54
Cited by
111
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.